Regenxbio (RGNX) Gross Margin (2014 - 2024)
Regenxbio (RGNX) posted Gross Margin of 70.22% for Q4 2024, up 20.81 percentage points from 49.41% a year earlier and up 21.41 percentage points from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Gross Margin (2014 - 2024) Analysis & Trends
For FY2024, Regenxbio's Gross Margin came in at 59.72%, up 0.95 percentage points from FY2023.
- Annual Gross Margin shows a five-year change of -16.89 percentage points (FY2019 to FY2024).
- In prior years, Regenxbio's Gross Margin was 58.76% in FY2023 (+7.15 pp), 51.61% in FY2022 (-37.37 pp), 88.98% in FY2021 (+12.09 pp) and 76.89% in FY2020 (+0.28 pp).
- Quarterly Gross Margin has run from a low of 29.26% in Q1 2022 to a high of 94.22% in Q4 2021 over five years.
- On a year-over-year basis, Gross Margin increased in three of the last eight quarters, with an average year-over-year change of +5.59 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q1 2023, with a gain of 49.25 percentage points; the weakest was Q1 2022, with a drop of 45.05 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 48.81% (Q3 2024), 52.55% (Q2 2024) and 72.58% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 72.78% |
| 10 | Regenxbio | 401.90 Mn | -531.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 70.22% |
| Sep 30, 2024 | 48.81% |
| Jun 30, 2024 | 52.55% |
| Mar 31, 2024 | 72.58% |
| Dec 31, 2023 | 49.41% |
| Sep 30, 2023 | 57.16% |
| Jun 30, 2023 | 52.57% |
| Mar 31, 2023 | 78.51% |
| Dec 31, 2022 | 59.22% |
| Sep 30, 2022 | 50.61% |
| Jun 30, 2022 | 60.33% |
| Mar 31, 2022 | 29.26% |
| Dec 31, 2021 | 94.22% |
| Sep 30, 2021 | 54.16% |
| Jun 30, 2021 | 55.44% |
| Mar 31, 2021 | 74.31% |
| Dec 31, 2020 | 52.17% |
| Sep 30, 2020 | 82.45% |
| Jun 30, 2020 | 71.73% |
| Mar 31, 2020 | 80.68% |
API Access
Regenxbio Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();